WH Ireland (LON: WHI) has confirmed that current levels of proxy votes indicate that the planned sale of the wealth management operations, departure from AIM and the winding up of the company will not be passed by shareholders. The outcome will not be certain until the general meeting tomorrow. The share price jumped 212.5% to 1.25p.
Oxford Biodynamics (LON: OBD) has, alongside the University of East Anglia, developed a test for Chronic Fatigue System or ME – there are around 400,000 sufferers in the UK. A suitable partner will be sought. The share price increased 28.6% to 0.675p.
Washing machine technology developer Xeros Technology (LON: XSG) has secured a joint development and product launch agreement with a global OEM that will use the technology in domestic washing machines in America. Commercialisation could be within 18 months. There are three more potential agreements like this one. A reduced loss of £2.8m is forecast for 2025. The share price recovered 16.7% to 1.75p.
Synthetic binders developer Aptamer (LON: APTA) has secured a £360,000 development contract with a top 3 global pharmaceutical company. The fee-for-service contract is to develop Optimer binders as targeted radiopharmaceuticals. Aptamer retains the rights for licensing. This takes work secured for this financial year to £1.03m. Last year’s revenues were £1.2m. The sales pipeline is worth £3.4m. The share price improved 15.8% to 1.1p.
Ariana Resources (LON: AAU) says that the second gold mine at Tavsan in Turkey is fully operational. Ariana Resources has a 23.5% stake in this mine which could produce up 30,000 ounces of gold each year at a cost of $1,500/ounce. At the current gold price, the company’s share of EBITDA could be £14m, according to Zeus. Cash could be used to invest in the Dokwe gold project in Zimbabwe. The share price is 14.9% higher at 1.925p.
Conroy Gold and Natural Resources (LON: CGNR) has raised £1.73m at 10p/share. The cash will finance geological work on interests in Ireland. The share price rose 11.9% to 11.75p.
FALLERS
Angle (LON: AGL) chairman Dr Jan Groen has become executive chairman, and the company is changing its name to CelLBxHealth. This is designed to reflect the new focus on circulating tumour cells (CTC) intelligence. There are plans to integrate existing proteomics and genomic assays with the company’s Parsortix technology. Cash should last until the first quarter of 2026, and more cash will be required. The share price is one fifth lower at 2.2p.
Oil and gas producer Serica Energy (LON: SQZ) has had further disruption at the Triton FPSO. A problem with the flare system temporarily halted production. This means that production will be lower than previous guidance of 29,000-32,000 boepd. The share price fell 10.4% to 191.2p.
Shares in pawnbroker Ramsdens (LON: RFX) slipped 5.16% to 367.5p despite Panmure Liberum raising its target share price from 385p to 450p on the back of the full year trading statement. This is due to the strong gold price and an 8% increase in the pawnbroking loan book to £11.5m. Net cash is estimated at £2.5m. The 2024-25 pre-tax profit has been edged up from £15.4m to £15.7m and the 2025-26 figure increased by 11% to £15.9m.